SHANGHAI DEXI BIOTECHNOLOGY CO., LTD. – Trademark Portfolio
Entity Type: 22
SHANGHAI DEXI BIOTECHNOLOGY CO., LTD. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 32 (Light Beverages) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include YUUHE. The owner is based in MINHANG DISTRICT, SHANGHAI.
ROOM 353, 3F, BUILDING 1, NO. 283
MINHANG DISTRICT, SHANGHAI 200000 , CN
Showing of trademarks Trademarks
Trademark Classifications
SHANGHAI DEXI BIOTECHNOLOGY CO., LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Frequently Asked Questions
How many trademarks does SHANGHAI DEXI BIOTECHNOLOGY CO., LTD. have?
SHANGHAI DEXI BIOTECHNOLOGY CO., LTD. has 3 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned.
What trademark classes does SHANGHAI DEXI BIOTECHNOLOGY CO., LTD. file in?
SHANGHAI DEXI BIOTECHNOLOGY CO., LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 32 (Light Beverages). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are SHANGHAI DEXI BIOTECHNOLOGY CO., LTD.'s most well-known trademarks?
SHANGHAI DEXI BIOTECHNOLOGY CO., LTD.'s registered trademark portfolio includes well-known marks such as YUUHE. These are among 1 currently registered trademark in the portfolio.
What is SHANGHAI DEXI BIOTECHNOLOGY CO., LTD.'s trademark registration success rate?
SHANGHAI DEXI BIOTECHNOLOGY CO., LTD. has a 33% trademark registration rate, with 1 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.